Shanghai Henlius Biotech Company

Shanghai Henlius Biotech provides clinical-stage biopharmaceutical services. The company focuses on the development, production and commercialization of mAb biosimilar drugs, bio-betters, and novel mAbs using cutting-edge technology.

Investors

Headquarters: China
Industry: Genomic and Epigenominc Instabillity
N/A
Register and Claim Ownership